Results 91 to 100 of about 53,450 (263)
Abstract Plasma‐derived medicinal products (PDMPs), particularly immunoglobulins (Igs), are essential treatments for numerous diseases, often serving as the primary therapeutic option and playing a critical role in patient care. The human origin of these products, however, can lead to supply constraints due to a lack of plasma collection, market ...
Miriam Belmonte+4 more
wiley +1 more source
Background The World Health Organization stated in March 2016 that there was scientific consensus that the mosquito-borne Zika virus was a cause of the neurological disorder Guillain-Barré syndrome and of microcephaly and other congenital brain ...
F. Krauer+8 more
semanticscholar +1 more source
HLA and immunological features of SARS-CoV-2-induced Guillain-Barré syndrome
We report the clinical and immunological features in a case of SARS-CoV-2-induced Guillain-Barré syndrome (Si-GBS), suggesting that (1) Si-GBS can develop even after paucisymptomatic COVID-19 infection; (2) a distinctive cytokine repertoire is associated
G. Gigli+8 more
semanticscholar +1 more source
We present a case of classic Miller Fisher Syndrome (MFS) variant of Guillain-Barre Syndrome (GBS) with detailed description in the difference between the internal and external ophthalmoplegia. They are different in their onset, duration, and recovery.
Golla Abhinav+5 more
doaj +1 more source
Abstract Respiratory acidosis and alkalosis are two of the four main acid‐base processes encountered in clinical practice. These two processes are tightly balanced by breathing. Identification and management of respiratory acid‐base disorders are important for clinicians, particularly when caring for patients with underlying pulmonary and neurological ...
Anne M. Tucker, Tami N. Johnson
wiley +1 more source
Zika fever, considered as an emerging disease of arboviral origin, because of its expanding geographic area, is known as a benign infection usually presenting as an influenza-like illness with cutaneous rash. So far, Zika virus infection has never led to
E. Oehler+9 more
semanticscholar +1 more source
Guillain-Barré syndrome in the COVID-19 era: just an occasional cluster?
In terms of epidemiology, Guillain-Barré syndrome (GBS) accounts for 1–2 new cases/100.000 inhabitants per year [1, 2]. During the last two weeks, in coincidence with the descending slope of the pandemic peak in our region (Friuli Venezia-Giulia, Italy),
G. Gigli+6 more
semanticscholar +1 more source
ABSTRACT Introduction Global ageing and the rise of chronic and progressive health conditions that lead to mobility changes will see increased need for manual wheelchair (MWC) provision and training. Existing training guidelines and training programmes are frequently tailored towards younger users.
Kimberly Charlton+3 more
wiley +1 more source
Zika Virus and the Guillain-Barré Syndrome - Case Series from Seven Countries.
During the past year and a half, Zika virus has been spreading rapidly throughout Latin America. In this letter, evidence for the Guillain–Barre syndrome being temporally associated with Zika virus transmission is presented.
Thais dos Santos+20 more
semanticscholar +1 more source
Guillain-Barré syndrome following COVID-19: a newly emerging post-infectious complication
A 57-year-old man presented with a progressive flaccid symmetrical motor and sensory neuropathy following a 1-week history of cough and malaise. He was diagnosed with Guillain-Barré syndrome secondary to COVID-19 and started on intravenous immunoglobulin.
Silas Webb+3 more
semanticscholar +1 more source